« Previous
Next »
Titles
- Gap assessment of hospitals' adoption of the just culture principles1
- Gap closed: the Affordable Care Act's impact on Asian Americans' health coverage1
- Gaps in coverage among people with pre-existing conditions1
- Gaps in coverage: a look at recent child health insurance trends1
- Gaps in health insurance: an all-American problem : findings from the Commonwealth Fund Biennial Health Insurance Survey1
- Gaston Memorial Hospital: driving quality improvement with data, guidelines, and real-time feedback1
- Gauging the progress of the National Health Information Technology Initiative: perspectives from the field1
- Gauging the threat: media coverage of pandemic and avian flu : based on interviews among journalists : conducted on behalf of : Trust for America's Health and Mailman School of Public Health at Columbia University1
- Geisinger Health System: achieving the potential of system integration through innovation, leadership, measurement, and incentives1
- Gender and the COVID-19 labor market downtown1
- Gene therapies for sickle cell disease: final evidence report1
- Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report1
- General clinical pharmacology considerations for neonatal studies for drugs and biological products1
- General considerations for animal studies intended to evaluate medical devices: guidance for industry and Food and Drug Administration staff1
- General principles for evaluating the abuse deterrence of generic solid oral opioid drug products1
- General principles for evaluating the human food safety of new animal drugs used in food-producing animals1
- Generic Drug User Fee Amendments of 2012: questions and answers related to self-identification of facilities, review of generic drug submissions, and inspections and compliance1
- Generic drug development: stakeholders’ views of risk evaluation and mitigation strategies differ : report to the Chairman, Committee on Energy and Commerce, House of Representatives1
- Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate1
- Generic drugs: FDA should make public its plans to issue and revise guidance on nonbiological complex drugs : report to Congressional requesters1